Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9225 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD7819 |
Suspended |
0.86 |
High Similarity |
NPD2532 |
Approved |
0.86 |
High Similarity |
NPD2534 |
Approved |
0.86 |
High Similarity |
NPD2533 |
Approved |
0.8506 |
High Similarity |
NPD7411 |
Suspended |
0.8503 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8446 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8435 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8397 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8313 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD1511 |
Approved |
0.828 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8272 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8207 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8205 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8205 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8176 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8146 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8125 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8121 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8117 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8108 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8063 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8063 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8026 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7964 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7947 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7929 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7927 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7927 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD920 |
Approved |
0.7871 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7832 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7829 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6100 |
Approved |
0.78 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7771 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7744 |
Intermediate Similarity |
NPD919 |
Approved |
0.774 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7662 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD411 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7566 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7548 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD2797 |
Approved |
0.75 |
Intermediate Similarity |
NPD3267 |
Approved |
0.75 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7452 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7439 |
Intermediate Similarity |
NPD37 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7427 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD9493 |
Approved |
0.741 |
Intermediate Similarity |
NPD4966 |
Approved |
0.741 |
Intermediate Similarity |
NPD4965 |
Approved |
0.741 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7386 |
Intermediate Similarity |
NPD943 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7346 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7329 |
Intermediate Similarity |
NPD17 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7293 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7293 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7209 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1201 |
Approved |
0.711 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7074 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7067
|
Intermediate Similarity |
NPD9269 |
Phase 2 |